SPT Bulls Eye Upside as Options Lean Bullish Ahead of Thursday Print

Sprout Social heads into its November 6 earnings report with options traders positioned more bullishly than usual, even as the stock trades well below the analyst consensus target.

The clearest pre-earnings signal is in options. The put/call ratio has dropped to 0.18, comfortably below its 20-day mean of 0.21, with call demand dominating in a way that marks one of the more bullish readings of the past year. The PCR sits close to its 52-week low of 0.11, suggesting investors are reaching for upside rather than hedging into the print. That enthusiasm follows a 18% rally over the past month, though the stock pulled back 3.3% on the week to close at $11.93 on Tuesday. Short interest, at 7.7% of the free float, has eased about 8% over the past week, and borrow conditions are relaxed: cost to borrow has fallen to 0.44%, down sharply from above 1% in mid-October, with availability at over 7,600%, meaning the lending pool is far from stressed. Positioning overall reads as cautiously optimistic rather than squeezed.

The bull and bear debate centres on whether Sprout Social's platform quality can overcome its revenue growth headwinds. Bulls point to the company's recognised strengths in social media workflow management, its subscription revenue model, and improving EPS momentum: the 90-day EPS momentum factor ranks in the 93rd percentile. Bears counter that macro-driven delays in enterprise software spending remain a live risk, that larger platforms could crowd Sprout Social on price, and that the EPS surprise factor ranks near the bottom of the universe at the 13th percentile, raising questions about whether the company tends to clear the bar it sets. Analyst targets have drifted upward since the Q2 print in August, when Stifel raised its target to $14 in October and Barclays moved to $12 after the last quarter, but the mean target across the coverage universe sits at around $10.67, fractionally below where the stock trades today. That means the consensus implies little incremental upside at current levels, even as individual bulls hold targets well above the current price.

The ownership picture carries one notable entry. Howard Justyn Russell, the Executive Chair, appears on the company's Schedule 13D register. Under ORTEX's first-party EDGAR data, that activist filing is on record as of December 2024 with a stake disclosed at 4.9%. Russell has been selling routinely under a 10b5-1 plan, most recently 40,000 shares in October at around $11.02, a pattern that is pre-arranged and therefore carries less informational weight than a discretionary sale. The broader 90-day net insider flow is modestly negative at roughly $1.4 million net sold, though the bulk of that reflects plan-driven and tax-withholding activity rather than open-market conviction selling. Meanwhile, BlackRock added materially to its position in the most recent quarter, lifting its reported stake to 14.5% of shares, the largest institutional holder on record. Several other names on the 13D/G register, including Vanguard's main vehicle and Cadian Capital, have exited or reduced well below 5%; per ORTEX's disclosure, those positions are as last disclosed and holders may fall below the reporting threshold without further filing.

The November 6 print will test whether the August quarter's 20% single-day surge, the most dramatic post-earnings reaction in the available history, reflected a durable turn in the business or simply a relief rally that the stock has only partially consolidated.